FLI1 and cancer: Taken together and considering the EWS-Fli1 oncogene addiction of the Ewing Sarcoma cells, our findings indicate that targeting the BET bromodomain signaling pathway in Ewing tumor can effectively disrupt the progression of this cancer through transcriptional repression of its main oncogenic driver [43].